Description

Overview

Sermorelin is a synthetic peptide identical to the first 29 amino acids of human growth hormone-releasing hormone (GHRH), the shortest portion of the 44-amino-acid hormone that retains full activity at the GHRH receptor. It is one of the longest-studied GHRH analogs and was previously used clinically in the United States before being discontinued by its manufacturer for commercial reasons.

Peptide Sciences Bio supplies Sermorelin 2mg for in-vitro and preclinical laboratory investigation. Every batch is supported by independent analytical testing and a published Certificate of Analysis.

Product Specifications

ProductSermorelin
Quantity2mg per vial
ClassGHRH analog (GRF 1-29 amide)
Also known asGRF (1-29) NH2
Length29 amino acids
Molecular formulaC149H246N44O42S
Molecular weight3357.9 g/mol
CAS number86168-78-7
FormLyophilized powder
Purity≥99% (HPLC)
DocumentationBatch-specific Certificate of Analysis

Structure & Background

Sermorelin has the unmodified native sequence of GRF (1-29) with a C-terminal amide. Because it carries no protective substitutions, it is broken down quickly by enzymes such as DPP-4, giving it a short half-life of minutes in research models. Researchers often use it as a reference compound against which modified analogs such as Mod GRF 1-29 and tesamorelin are compared.

GHRH and GHRP Synergy

Growth hormone release is controlled by two main stimulatory signals. GHRH acts on the GHRH receptor and raises cAMP in pituitary somatotrophs. Ghrelin and the synthetic GHRPs act on a separate receptor, GHS-R1a, which works through calcium signaling and also counteracts somatostatin, the hormone that suppresses GH release. Because they use different pathways, research has consistently found that combining a GHRH analog with a GHRP produces a greater GH response than either compound alone, often more than the sum of the two. This synergy is the main reason these compounds are studied together.

Mechanisms Studied

Research on Sermorelin has examined:

  • GHRH receptor activation: stimulation of pituitary somatotrophs through cAMP signaling.
  • Physiological GH release: growth hormone secretion subject to normal somatostatin feedback.
  • Pituitary reserve testing: historical use in research on pituitary responsiveness.
  • Combination effects: synergy with GHRPs such as GHRP-2, GHRP-6 and ipamorelin.

Areas of Study

  • Growth hormone axis physiology
  • Age-related changes in GH secretion
  • Sleep and GH secretion research
  • Comparative GHRH analog pharmacology

Sermorelin has been studied in human clinical trials, but those results apply to pharmaceutical-grade investigational material under clinical supervision. This research-grade product is not an approved drug product and is not intended for human use.

Related Research Peptides

Quality & Testing

Every batch of Sermorelin is independently tested for identity and purity before release. Testing includes high-performance liquid chromatography (HPLC) to confirm purity and mass spectrometry (MS) to confirm molecular identity. The batch-specific Certificate of Analysis is available on this page and in our COA library, so researchers can verify the exact material they receive.

Storage & Handling

  • Store lyophilized Sermorelin at −20°C, protected from light and moisture.
  • Short-term storage at 2–8°C is acceptable for lyophilized material.
  • Allow the vial to reach room temperature before opening to limit condensation.
  • Handle using standard laboratory practices and appropriate protective equipment.

For laboratory solution preparation, see our Peptide Reconstitution Guide.

Frequently Asked Questions

What is Sermorelin?

Sermorelin is a synthetic peptide matching the first 29 amino acids of growth hormone-releasing hormone. It is studied in research on growth hormone secretion.

How does sermorelin differ from CJC-1295 no DAC?

Sermorelin has the native GRF (1-29) sequence. CJC-1295 no DAC (Mod GRF 1-29) carries four substitutions that make it more resistant to enzymatic breakdown.

Is Sermorelin approved for human use?

Sermorelin has been evaluated in human clinical trials. Regardless of its regulatory status, this product is a research-grade material, not an approved drug product, and is not intended for human or veterinary use. Peptide Sciences Bio sells it strictly for laboratory research.

How should Sermorelin be stored?

Lyophilized Sermorelin should be stored at −20°C, away from light and moisture. Short-term storage at 2–8°C is acceptable.

What does the Certificate of Analysis include?

Each COA reports the batch number, HPLC purity results and mass spectrometry confirmation of molecular identity for that specific batch.

Research Use Only

This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis, treatment or prevention of any condition. Purchase is restricted to buyers who agree to our Terms of Sale.

Additional information​

Product FormLyophilized Powder (Vial)

Sermorelin 2mg

$35.00

Sermorelin 2mg is the 29-amino-acid active fragment of native growth hormone-releasing hormone (GRF 1-29 amide). It is studied in preclinical research on the growth hormone and growth factor axis. Supplied as a lyophilized powder at ≥99% purity (HPLC), with batch-specific COA available. For laboratory research use only.

Shipping & 30 Days Return

Worldwide tracked delivery. Dispatched within 24 hours of order confirmation.

Not satisfied? Return any item within 10 days for a full refund, no questions asked.